TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 1518636

Group type: EXPERIMENTAL
Intervention: Lidocaine with epinephrine concentration of 1:200,000
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lidocaine with epinephrine concentration of 1:100,000
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lidocaine alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lidocaine with epinephrine concentration of 1:50,000
Number of subjects: 0
Study: 6387286

Group type: EXPERIMENTAL
Intervention: Blood cardioplegia
Number of subjects: 90
Study: 31511967

Group type: EXPERIMENTAL
Intervention: Path integral approach to generating functions for multistep post-transcription and post-translation processes.
Number of subjects: 6
Study: 29112721

Group type: EXPERIMENTAL
Intervention: Immediate condition (tailored report received at the well-child visit)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Delayed condition (tailored report received at the end of the study)
Number of subjects: 0
Study: 26320696

Group type: EXPERIMENTAL
Intervention: Optimized hybrid ESD
Number of subjects: 70

Group type: COMPARATOR
Intervention: ESD
Number of subjects: 70
Study: 24470003

Group type: EXPERIMENTAL
Intervention: Expressive writing (EW)
Number of subjects: 277

Group type: COMPARATOR
Intervention: Neutral writing (NW)
Number of subjects: 277
Study: 23030576

Group type: EXPERIMENTAL
Intervention: Text with symbols format
Number of subjects: 157

Group type: COMPARATOR
Intervention: Text-only format
Number of subjects: 157

Group type: COMPARATOR
Intervention: Symbols-only format
Number of subjects: 157
Study: 20687838

Group type: EXPERIMENTAL
Intervention: 3.75 microg AS03A-adjuvanted H1N1 2009 vaccine (1 dose)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: 3.75 microg AS03A-adjuvanted H1N1 2009 vaccine (2 doses)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: 3.75 microg AS03A-adjuvanted H1N1 2009 vaccine (1 or 2 doses)
Number of subjects: 240
Study: 18487212

Group type: EXPERIMENTAL
Intervention: Androgen priming with anastrozole 1 mg on cycle days 2, 3, and 4, hCG 1250 IU, cetrorelix 3 mg on cycle day 2, rFSH 150 IU from cycle day 5
Number of subjects: 103

Group type: COMPARATOR
Intervention: Control group with flexible antagonist protocol
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Androgen priming
Number of subjects: 103
Study: 15643540

Group type: EXPERIMENTAL
Intervention: Elite and professional cyclists
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: Members of the Italian national cross‐country ski team
Number of subjects: 143

Group type: COMPARATOR
Intervention: Sedentary healthy controls
Number of subjects: 143
Study: 14632733

Group type: EXPERIMENTAL
Intervention: ThinPrep® (TP)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Conventional smears (CS)
Number of subjects: 120
Study: 10228629

Group type: EXPERIMENTAL
Intervention: EMLA pre-treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Capsaicin with EMLA
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vehicle placebo pre-treatment
Number of subjects: 0
Study: 8909454

Group type: EXPERIMENTAL
Intervention: Methazolamide (average dose 168 mg/day)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 1985289

Group type: EXPERIMENTAL
Intervention: azathioprine (AZA) 3.0 mg/kg daily
Number of subjects: 59

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 59
Study: 6358645

Group type: EXPERIMENTAL
Intervention: Solcoseryl eye gel
Number of subjects: 92

Group type: COMPARATOR
Intervention: Control group (neomycin and bacitracin)
Number of subjects: 92
Study: 31454328

Group type: EXPERIMENTAL
Intervention: SureFil SDR Flow (SDR)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Filtek Bulk Fill Flowable Restorative (Filtek Bulk)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Filtek Z250 XT (Z250)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Untreated teeth (Control group)
Number of subjects: 80
Study: 27924049

Group type: EXPERIMENTAL
Intervention: 2-day longitudinal NIHSS data
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 2-day trajectory subgroup variable
Number of subjects: 0
Study: 24576016

Group type: EXPERIMENTAL
Intervention: Escitalopram
Number of subjects: 240

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 240
Study: 25675560

Group type: EXPERIMENTAL
Intervention: Electroacupuncture at Neiguan (PC 6) and Jianshi (PC 5) combined with granisetron injection
Number of subjects: 72

Group type: COMPARATOR
Intervention: Electroacupuncture at sham-point 1 and sham-point 2
Number of subjects: 72
Study: 21917634

Group type: EXPERIMENTAL
Intervention: High-fat overfeeding (HFO) for 5 days in LBW subjects
Number of subjects: 20
Study: 19890207

Group type: EXPERIMENTAL
Intervention: Caffeinated soda (32 oz daily for 1 week)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Noncaffeinated soda (32 oz daily for 1 week)
Number of subjects: 0
Study: 17302650

Group type: EXPERIMENTAL
Intervention: Collective exercise program (1 hour, twice weekly of walk, strength, balance, and flexibility training)
Number of subjects: 134

Group type: COMPARATOR
Intervention: Routine medical care
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Collective exercise program
Number of subjects: 134
Study: 14693614

Group type: EXPERIMENTAL
Intervention: UVB irradiation
Number of subjects: 8
Study: 12478880

Group type: EXPERIMENTAL
Intervention: Transdermal nicotine (5 mg/16 hrs)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 9785589

Group type: EXPERIMENTAL
Intervention: MIB‐1 staining indices (MIB‐SI, %) in meningiomas with chromosomal aberrations
Number of subjects: 10

Group type: COMPARATOR
Intervention: MIB‐1 staining indices (MIB‐SI, %) in meningiomas without chromosomal aberrations
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: MIB‐1 staining indices (MIB‐SI, %) in benign meningiomas
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: MIB‐1 staining indices (MIB‐SI, %) in atypical meningiomas
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: MIB‐1 staining indices (MIB‐SI, %) in anaplastic meningiomas
Number of subjects: 10
Study: 7665718

Group type: EXPERIMENTAL
Intervention: Quinine sulfate (200 to 300 mg every night)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo or vitamin E
Number of subjects: 0
Study: 1942014

Group type: EXPERIMENTAL
Intervention: Vertical strip pattern of breast self-examination (BSE)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Sliding finger palpation technique
Number of subjects: 97

Group type: COMPARATOR
Intervention: Concentric circle and radial spoke patterns
Number of subjects: 97
Study: 7305784

Group type: EXPERIMENTAL
Intervention: Conray 420 (sodium iothalamate)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Urografin 370 (methylglucamine diatrizoate with sodium diatrizoate)
Number of subjects: 200
Study: 31619325

Group type: EXPERIMENTAL
Intervention: Twice-daily BG testing
Number of subjects: 32

Group type: COMPARATOR
Intervention: 4-times-daily BG testing
Number of subjects: 32
Study: 29963781

Group type: EXPERIMENTAL
Intervention: Repaglinide (Repa group)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Sulfonylurea (SU group)
Number of subjects: 57
Study: 28273933

Group type: EXPERIMENTAL
Intervention: Active tDCS (1 mA, 20 min)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 40
Study: 26358287

Group type: EXPERIMENTAL
Intervention: Resuspended NPH insulin (R+)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Nonresuspended NPH insulin (R- horizontal)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Nonresuspended NPH insulin (R- up)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Nonresuspended NPH insulin (R- down)
Number of subjects: 11
Study: 24898240

Group type: EXPERIMENTAL
Intervention: Cholecalciferol (1200 IU/d)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Cholecalciferol (1200 IU/d) excluding diabetic subjects
Number of subjects: 130
Study: 22257422

Group type: EXPERIMENTAL
Intervention: Inhaled N-acetylcysteine (NAC) 352.4 mg by inhalation twice daily
Number of subjects: 76

Group type: COMPARATOR
Intervention: Control group (no therapy)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Inhaled N-acetylcysteine (NAC)
Number of subjects: 76
Study: 19463133

Group type: EXPERIMENTAL
Intervention: Nifedipine RD
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of calcium antagonists and ACE inhibitors
Number of subjects: 0

Group type: COMPARATOR
Intervention: Enalapril
Number of subjects: 0
Study: 17963316

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham-acupuncture (placebo)
Number of subjects: 0
Study: 15359902

Group type: EXPERIMENTAL
Intervention: Latanoprost (Lat)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Timolol gel-forming solution (Tg)
Number of subjects: 47
Study: 11246234

Group type: EXPERIMENTAL
Intervention: MicroStent(R) II (MSII)
Number of subjects: 661

Group type: COMPARATOR
Intervention: Palmaz‐Schatz (PS) stent
Number of subjects: 661
Study: 9832111

Group type: EXPERIMENTAL
Intervention: Energy delivery at successful target sites
Number of subjects: 332

Group type: COMPARATOR
Intervention: Energy delivery at unsuccessful target sites
Number of subjects: 332
Study: 7862918

Group type: COMPARATOR
Intervention: Nicotine patch delivering 0 mg per 24 h
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Nicotine patch delivering 22 mg per 24 h
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Nicotine patch delivering 44 mg per 24 h
Number of subjects: 10
Study: 2570604

Group type: EXPERIMENTAL
Intervention: Neuroleptanesthesia
Number of subjects: 21

Group type: COMPARATOR
Intervention: Thoracic epidural anesthesia
Number of subjects: 21
Study: 79761

Group type: EXPERIMENTAL
Intervention: Co-trimoxazole
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (non-absorbable antibiotics)
Number of subjects: 30
Study: 31742685

Group type: EXPERIMENTAL
Intervention: Modular cognitive-behavioral therapy (CBT) consisting of 30 sessions targeting psychotic experiences and depression/anxiety
Number of subjects: 58

Group type: COMPARATOR
Intervention: Supportive intervention (control)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Modular cognitive-behavioral therapy (CBT)
Number of subjects: 58
Study: 30772851

Group type: EXPERIMENTAL
Intervention: Crosslinked porcine dermis mesh (Permacol)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-crosslinked porcine dermis mesh (Strattice)
Number of subjects: 0
Study: 28853131

Group type: EXPERIMENTAL
Intervention: Peer-mediated health education workshop on tobacco use
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Peer-mediated health education workshop on nutrition/physical activity
Number of subjects: 0
Study: 25871593

Group type: EXPERIMENTAL
Intervention: Sensory-adapted dental environment (SADE)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Regular dental environment
Number of subjects: 44
Study: 23672672

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 156

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 156
Study: 21426572

Group type: EXPERIMENTAL
Intervention: Bucco-lingual technique with professional cross-brushing five times per year
Number of subjects: 284

Group type: COMPARATOR
Intervention: Control group with oral health education and supervised toothbrushing four times per year
Number of subjects: 284
Study: 19480230

Group type: EXPERIMENTAL
Intervention: STD home
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: STD+PSG lab
Number of subjects: 80

Group type: COMPARATOR
Intervention: PSG lab
Number of subjects: 80

Group type: COMPARATOR
Intervention: PSG+STD lab
Number of subjects: 80
Study: 17086470

Group type: EXPERIMENTAL
Intervention: Multifaceted intervention (faxed physician reminders with osteoporosis treatment guidelines and patient counseling)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Multifaceted intervention
Number of subjects: 102

Group type: COMPARATOR
Intervention: Delayed intervention for controls (after 6 months)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 102
Study: 15113950

Group type: EXPERIMENTAL
Intervention: Processed complementary food (CF)
Number of subjects: 309

Group type: COMPARATOR
Intervention: Unprocessed placebo
Number of subjects: 309
Study: 11686824

Group type: EXPERIMENTAL
Intervention: New dentifrice containing potassium nitrate, stannous fluoride, and sodium fluoride
Number of subjects: 186

Group type: COMPARATOR
Intervention: Fluoride dentifrice
Number of subjects: 186

Group type: COMPARATOR
Intervention: Sensodyne F
Number of subjects: 186
Study: 9217756

Group type: EXPERIMENTAL
Intervention: Ramipril
Number of subjects: 352

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 352
Study: 8424508

Group type: EXPERIMENTAL
Intervention: Epidural fentanyl infusion (10 micrograms/mL)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Patient-controlled analgesia (PCA) with morphine (1.0 mg/mL)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Epidural fentanyl infusion
Number of subjects: 36

Group type: COMPARATOR
Intervention: Patient-controlled analgesia (PCA) with morphine
Number of subjects: 36
Study: 3621992

Group type: EXPERIMENTAL
Intervention: 0.05% clobetasol propionate ointment applied once daily for 2 weeks
Number of subjects: 12

Group type: COMPARATOR
Intervention: 1 week of active treatment followed by 1 week of vehicle alone
Number of subjects: 12
Study: 30587217

Group type: EXPERIMENTAL
Intervention: Mindfulness-based group psychotherapy ("Mind it!") in addition to existing treatment regime
Number of subjects: 340
Study: 27107396

Group type: EXPERIMENTAL
Intervention: DCYA (lipiodol-diluted cyanoacrylate)
Number of subjects: 30

Group type: COMPARATOR
Intervention: UCYA (undiluted cyanoacrylate)
Number of subjects: 30
Study: 24258302

Group type: EXPERIMENTAL
Intervention: SCT factors (Daydreaming)
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: SCT factors (Sleepy/Tired)
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: SCT factors (Working Memory Problems)
Number of subjects: 165
Study: 23789780

Group type: EXPERIMENTAL
Intervention: Distance walked in 6 min before surgery
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Age of patients
Number of subjects: 112
Study: 21135267

Group type: EXPERIMENTAL
Intervention: Prophylactic cranial irradiation (PCI)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Observation
Number of subjects: 0
Study: 18237799

Group type: EXPERIMENTAL
Intervention: Intensity modulated photon radiotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Proton radiotherapy
Number of subjects: 0
Study: 16371493

Group type: EXPERIMENTAL
Intervention: Motivational shouting exercises
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Brief yoga exercises
Number of subjects: 90

Group type: COMPARATOR
Intervention: No intervention control condition
Number of subjects: 90
Study: 12525460

Group type: EXPERIMENTAL
Intervention: Congenital uterine anomalies in women with recurrent miscarriage
Number of subjects: 2485

Group type: COMPARATOR
Intervention: Congenital uterine anomalies in low risk women
Number of subjects: 2485

Group type: EXPERIMENTAL
Intervention: Arcuate and subseptate uteri in recurrent miscarriage group
Number of subjects: 2485

Group type: COMPARATOR
Intervention: Arcuate and subseptate uteri in low risk women
Number of subjects: 2485
Study: 10986782

Group type: EXPERIMENTAL
Intervention: Iron-fortified infant cereal (10.2 mg iron) and pureed meat (0.75-1.7 mg iron) with whole cow milk for six months
Number of subjects: 97

Group type: COMPARATOR
Intervention: No dietary intervention (control group)
Number of subjects: 97
Study: 9019575

Group type: EXPERIMENTAL
Intervention: Laryngeal mask airway (LMA)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Tracheal tube (TT)
Number of subjects: 60
Study: 1732264

Group type: EXPERIMENTAL
Intervention: A‐V Impulse System (venous foot pump)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 84
Study: 3840381

Group type: EXPERIMENTAL
Intervention: Atracurium
Number of subjects: 0

Group type: COMPARATOR
Intervention: Alcuronium
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Train-of-four stimulation
Number of subjects: 0
Study: 30995645

Group type: EXPERIMENTAL
Intervention: 0.15% ropivacaine + 0.02 μg × kg‐1 × h‐1 DEX (group D1)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: 0.15% ropivacaine + 0.05 μg × kg‐1 × h‐1 DEX (group D2)
Number of subjects: 3

Group type: COMPARATOR
Intervention: 0.15% ropivacaine (group C)
Number of subjects: 3
Study: 29120262

Group type: EXPERIMENTAL
Intervention: Brimonidine Tartrate Ophthalmic Solution, 0.025%
Number of subjects: 57

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 57
Study: 27090436

Group type: EXPERIMENTAL
Intervention: Cholesterol treatment discussion
Number of subjects: 646

Group type: EXPERIMENTAL
Intervention: Statin prescription
Number of subjects: 646
Study: 24567312

Group type: EXPERIMENTAL
Intervention: Eau de Dalibour (84 infants)
Number of subjects: 178

Group type: COMPARATOR
Intervention: Ethanol (94 infants)
Number of subjects: 178
Study: 21849206

Group type: EXPERIMENTAL
Intervention: FVIII levels determined by one-stage clotting (FVIII:C) and chromogenic (FVIII:Ch) assays; Thrombin generation measured using the Calibrated Automated Thrombogram (CAT); D-Dimer measured by immuno-turbidometric assay.
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Prolonged anticoagulation therapy suggested for patients with high FVIII and increased TG.
Number of subjects: 91
Study: 20734046

Group type: EXPERIMENTAL
Intervention: Gentamicin-containing collagen sponge (Collatamp(®))
Number of subjects: 161

Group type: COMPARATOR
Intervention: No additional treatment (Control)
Number of subjects: 161
Study: 18353618

Group type: EXPERIMENTAL
Intervention: Naltrexone
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 16249698

Group type: EXPERIMENTAL
Intervention: Probenecid (PBCD) and protease inhibitors (PIs)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 12728198

Group type: EXPERIMENTAL
Intervention: Psychiatric treatment administered by five psychiatrists on an outpatient basis for one year.
Number of subjects: 51

Group type: COMPARATOR
Intervention: As-usual treatment from primary care physicians.
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Psychiatric treatment elsewhere (not specified).
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Treatment group (psychiatric treatment).
Number of subjects: 51
Study: 10591045

Group type: EXPERIMENTAL
Intervention: Topical acetylsalicylic acid
Number of subjects: 40

Group type: COMPARATOR
Intervention: Lidocaine
Number of subjects: 40
Study: 7802369

Group type: EXPERIMENTAL
Intervention: Active compression-decompression CPR (ACD-CPR)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Standard CPR (S-CPR)
Number of subjects: 16
Study: 2128228

Group type: EXPERIMENTAL
Intervention: Phosphatidylserine (PS) 400 mg/daily
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 686311

Group type: EXPERIMENTAL
Intervention: Tubocurarine 0.05 mg/kg
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Gallamine 0.3 mg/kg
Number of subjects: 45

Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 45
Study: 30488093

Group type: EXPERIMENTAL
Intervention: External Physical Vibration Lithecbole (EPVL) therapy
Number of subjects: 271

Group type: COMPARATOR
Intervention: Control group (no EPVL therapy)
Number of subjects: 271
Study: 29974219

Group type: EXPERIMENTAL
Intervention: MR‐HSG
Number of subjects: 40

Group type: COMPARATOR
Intervention: X‐HSG
Number of subjects: 40
Study: 28666965

Group type: EXPERIMENTAL
Intervention: Individualized antibiotic duration (discontinued 48 hours after clinical stability, with at least five days of total antibiotic treatment)
Number of subjects: 260

Group type: COMPARATOR
Intervention: Standard antibiotic duration
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: Individualized antibiotic duration
Number of subjects: 260
Study: 26003508

Group type: EXPERIMENTAL
Intervention: MDMA (25, 50, 100 mg)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Cannabis (THC 300 µg/kg)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Cocaine (HCl 300 mg)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study: 23052987

Group type: EXPERIMENTAL
Intervention: Caspofungin (50 mg or 70/50 mg loading dose on Day 1)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Micafungin (150 mg)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Caspofungin
Number of subjects: 120

Group type: COMPARATOR
Intervention: Micafungin
Number of subjects: 120
Study: 21967254

Group type: EXPERIMENTAL
Intervention: Tacrolimus (n=11) with steroids for 5 days and azathioprine (1 mg/kg) if WBC ≥ 4000 cells/cm³
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Sirolimus (n=10) with steroids for 5 days and azathioprine (1 mg/kg) if WBC ≥ 4000 cells/cm³
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Sirolimus after 2 months of Tacrolimus in Phase 2 (n=20)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Steroid-free regimen
Number of subjects: 41
Study: 19567088

Group type: EXPERIMENTAL
Intervention: Cochlear implantation in CI recipients with GJB2 gene mutation
Number of subjects: 253

Group type: COMPARATOR
Intervention: Cochlear implantation in CI recipients without GJB2 gene mutation (control group)
Number of subjects: 253
Study: 16452698

Group type: COMPARATOR
Intervention: Interventions for major depressive disorder
Number of subjects: 1848
Study: 15125910

Group type: EXPERIMENTAL
Intervention: Single auditory cue (SA)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Repetitive auditory cues (RA)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Repetitive cutaneous cues (RC)
Number of subjects: 14

Group type: COMPARATOR
Intervention: No cue (NC)
Number of subjects: 14
Study: 12144211

Group type: EXPERIMENTAL
Intervention: Foam probe cover
Number of subjects: 26

Group type: COMPARATOR
Intervention: Hydrogel probe cover
Number of subjects: 26
Study: 9669421

Group type: EXPERIMENTAL
Intervention: Cockcroft‐Gault estimated CrCl
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: 24‐hour CrCl
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: CX3 simultaneous CrCl
Number of subjects: 118

Group type: COMPARATOR
Intervention: fGFR
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Fractional excretion of creatinine
Number of subjects: 118
Study: 7752827

Group type: EXPERIMENTAL
Intervention: Coenzyme Q10 treatment for 4 weeks
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control conditions (placebo)
Number of subjects: 6